Avidity Partners Management LP Shattuck Labs, Inc. Transaction History

Avidity Partners Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.22 - $8.89 $696,300 - $1.47 Million	-165,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.36 - $21.08 $15.5 Million - $39.2 Million	-1,860,000 Reduced 91.85%	165,000 $1.4 Million
Q3 2021 Nov 15, 2021	BUY	$17.57 - $28.95 $1.49 Million - $2.45 Million	84,800 Added 4.37%	2,025,000 $41.3 Million
Q2 2021 Aug 16, 2021	BUY	$24.14 - $37.68 $14.7 Million - $23 Million	609,815 Added 45.84%	1,940,200 $56.2 Million
Q1 2021 May 17, 2021	BUY	$27.92 - $52.5 $10.9 Million - $20.6 Million	391,572 Added 41.71%	1,330,385 $38.9 Million
Q4 2020 Feb 16, 2021	BUY	$19.0 - $57.61 $17.8 Million - $54.1 Million	938,813 New	938,813 $49.2 Million

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.